Megadeals Drive Strong ECM Start to 2026 Amid Middle East Conflict Uncertainty
Event summary
- Global ECM issuance reached USD 256.8 billion in Q1 2026, up 43% year-over-year.
- Eight of the top ten March deals were follow-ons, including EQT's Galderma cleanup and Blackstone/Carlyle/Hellman & Friedman's Medline sell-down.
- The Americas led regional activity with USD 132.1 billion in ECM issuance, up 64% year-over-year.
- Middle East conflict has complicated issuance windows for the remainder of 2026 due to higher energy costs and geopolitical uncertainty.
The big picture
The first quarter of 2026 saw strong ECM activity driven by megadeals, but geopolitical volatility from the Middle East conflict has introduced uncertainty. Investors are favoring larger, more liquid transactions as they navigate higher energy costs and potential disruptions in key shipping lanes. The potential for US mega listings later this year could significantly impact overall ECM volumes, with SpaceX viewed as the most likely candidate to go public first.
What we're watching
- Geopolitical Risk
- How prolonged Middle East conflict will affect energy prices and ECM deal flow.
- Mega Listings
- Whether SpaceX, Anthropic, or OpenAI listings could materially shift ECM volumes in 2026.
- Investor Sentiment
- The pace at which investors deploy capital amid reduced consumer incomes and paused global rate cuts.
Related topics